Evaluation of efficacy of Kremezin in peripheral arterial disease patients with chronic kidney disease.

Next Previous
Trial Profile

Evaluation of efficacy of Kremezin in peripheral arterial disease patients with chronic kidney disease.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2016

At a glance

  • Drugs Charcoal (Primary)
  • Indications Kidney disorders; Peripheral arterial disorders
  • Focus Therapeutic Use

    • Most Recent Events

    • 20 Jul 2016 Planned End Date changed from 31 Mar 2017 to 31 Mar 2018.
    • 28 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top